Le Lézard
Classified in: Health
Subject: FVT

Syra Health to Participate in Healthcare Capital Markets & Innovation Summit in Columbus, OH

CARMEL, Ind., May 29, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company that is powering better health by providing meaningful solutions, announced today that it will participate in the Healthcare Capital Markets and Innovation Summit on Wednesday, June 5, 2024 at the Renaissance Columbus Downtown Hotel in Columbus, Ohio.

The fourth annual conference is focused on deal-making and networking with industry leaders, company executives, and private equity firms focused on driving growth.

Vice President of Syra Health's Behavioral and Mental Health Business Unit, Dr. Srikant Devaraj, will speak as part of the Emerging Trends in Behavioral and Mental Health panel taking place at 3:15 p.m. ET on June 5. Syra Health's CEO, Dr. Deepika Vuppalanchi, will deliver the Company's presentation at 4:00 p.m. ET the same day in the event's main ballroom.

Recordings of the presentations will be made available following the event, under the "Presentations" section of Syra Health's Investor website at Presentations - Syra Health.


Syra Health is a healthcare technology company that is powering better health in challenging areas such as behavioral and mental health, digital health, and population health, by providing innovative and meaningful solutions. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health serves everyone working in healthcare. For more information, visit www.syrahealth.com.

For more information, please contact:

For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
[email protected]

For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
[email protected]

SOURCE Syra Health

These press releases may also interest you

at 17:05
Mirum Pharmaceuticals, Inc. today announced that it will host an investor call on Monday, June 17 at 8:30 a.m. ET to share interim analysis results from the Volixibat VANTAGE Phase 2b study in primary biliary cholangitis (PBC) and the Volixibat...

at 14:00
Eczema, a skin inflammatory disease that causes dry, itchy and inflamed skin, affects millions worldwide. Eczema is associated with an altered skin microbiome and higher colonization by Staphylococcus aureus. The study, led at New York Medical by...

at 13:38
Thousands of participants raised $1.63 million at the 11th annual Journey to Conquer Cancer ? a new record for this event, presented by Starlight Investments benefiting the Princess Margaret Cancer Centre on June 16, 2024. This inclusive family and...

at 08:00
Please be advised that the Honourable Patty Hajdu, Minister of Indigenous Services, will make a funding announcement for the Weeneebayko Area Health Authority. Date:  Monday, June 17, 2024Time: 12:00 p.m. (ET) Where:House of Commons Foyer (West...

at 07:45
Today, Crisis Prevention Institute (CPI) announced the launch of Reframing Behavior ? its new groundbreaking, subscription-based, schoolwide training program that unpacks the latest neuroscience to help all educators build a more positive, supportive...

at 07:05
Positive results from the ECHO Phase III trial showed AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab demonstrated a statistically significant and clinically meaningful improvement in progression-free survival...

News published on and distributed by: